New Market Research Report: Ukraine Pharmaceuticals & Healthcare Report Q1 2015

From: Fast Market Research, Inc.
Published: Tue Dec 16 2014

In line with our view, price inflation is contributing to pharmaceutical volume drop-off in Ukraine. Sales have risen in local currency terms, but declined in real terms. We see the remainder of 2014 and 2015 as being particularly challenging within Ukraine owing to upcoming headwinds and distressed market conditions.

Headline Expenditure Projections

* Pharmaceuticals: UAH36.20bn (USD4.44bn) in 2013 to UAH40.80bn (USD3.55bn) in 2014; +12.7% in local currency terms and -20.1% in US dollar terms.
* Healthcare: UAH109.92bn (USD13.48bn) in 2013 to UAH118.47bn (USD10.30bn) in 2014; 7.8% in local currency terms and -23.6% in US dollar terms.

Full Report Details at

Risk/Reward Ratings: Ukraine's operating environment remains extremely unfavourable at present, especially in the light of the present economic instability and the country's civil unrest in Eastern Ukraine.

Key Trends & Developments

* At a recent meeting between the acting health minister Vasyl Lazorshynets and the World health Organization, the health minister indicated the possibility of direct procurement of medicines and vaccines from multinational drugmakers.
* The Ukrainian government suspended Health Minister Oleh Musiy and his first Deputy Minister Ruslan Saliutin for failing to tender procurements of required medicines.
* Pharmacy sales in local currency terms continue to rise but volumes decline significantly, reflecting the sudden devaluation of the hryvnia and the reliance on imports within Ukraine.
* The Ukrainian parliament is discussing laws to harmonise pharmaceutical legislation in line with European standards
* The Ukrainian Ministry of Health is proposing an order to the State Service For Drug Control enabling medicines imported from the USA, the EU, Switzerland, Japan, UK, Australia and Canada to be registered under expedited guidelines, based on regulatory evidence from those countries.
* Reference pricing to be introduced for all drugs procured by state agencies in Ukraine.


The Ukraine Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Ukraine Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Ukrainian pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's independent pharmaceutical and healthcare industry forecasts for Ukraine to test other views - a key input for successful budgeting and strategic business planning in the Ukrainian pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Turkey Pharmaceuticals & Healthcare Report Q1 2015
- Slovenia Pharmaceuticals & Healthcare Report Q1 2015
- Thailand Pharmaceuticals & Healthcare Report Q1 2015
- Kenya Pharmaceuticals & Healthcare Report Q1 2015
- Jordan Pharmaceuticals & Healthcare Report Q1 2015
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »